Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489424 · ClinicalTrials.gov registry record · Phase 4
Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass
A Phase 4 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 793
- Enrollment target
NCT00489424 is a Phase 4 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 793 participants.
The verdict
NCT00489424, a Phase 4 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 793 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of acetaminophen or fluvastatin in reducing the rate of occurrence and the severity of post dose symptoms that may occur during the 3 day period following a zoledronic acid infusion in post menopausal women with low bone mass.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Fluvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 793 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489424
The ClinicalTrials.gov registry entry for NCT00489424 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 793 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00489424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00489424 about?
NCT00489424 is a clinical study titled "Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass". This study will evaluate the efficacy of acetaminophen or fluvastatin in reducing the rate of occurrence and the severity of post dose symptoms that may occur during the 3 day period following a zoledronic acid infusion in post menopausal women with low bone mass.
What is the current status of trial NCT00489424?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 793 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00489424?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Fluvastatin (DRUG).
Who is sponsoring clinical trial NCT00489424?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.